FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma
New flexible arrays are lighter, thinner and designed to improve comfort for Optune Gio users ROOT, Switzerland--(BUSINESS WIRE)-- Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug ...
Novocure (NVCR) announced that the FDA approved its new head flexible electrode, or HFE, transducer arrays for use with Optune Gio for the treatment of adult patients with glioblastoma multiforme, or ...
July 6 (UPI) --Northrop Grumman reports it has received a contract from the U.S. Navy to produce Transducer Array/Nose Shell Assemblies for MK 48 heavyweight torpedoes, the company announced on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback